You have been chosen to receive this valuable information.

View in browser

Pharmaceutical Technology
Pharmaceutical Technology

COVID-19 and Clinical Trials White Paper

 

What is the latest on the impact COVID-19 is having on clinical trials worldwide?

 

    VIEW REPORT NOW    

As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata solutions can help address your COVID-19 related challenges. Read our latest report.

  • New: Results of a global survey of investigator sites about the impact of COVID-19 on their clinical trials

  • Updated: Metrics on patient enrollment by country and therapeutic area (full month data for March and April)

  • Updated: Metrics of Impact of COVID-19 on number of site visits.

  • New: Summary table of the current 8 vaccine clinical trials for COVID-19

  • New: Launched the COVID-19 Symptom Tracker as part of Medidata’s Patient Portal, myMedidata

  • New: The updated MedDRA 23.0 dictionary supporting new COVID-19 terms and revisions is now available to clients using Rave Coder.

    ACCESS NOW    

 

Privacy Policy   •   Trademarks   •   Legal

Copyright © 2020 Medidata Solutions, Inc.
350 Hudson St, 9th Floor, New York, NY 10014

1-866-MEDIDATA (633-4328)   •   medidata.com

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trials, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.